Alkermes plc

ALKS ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $191.3M $186.4M $181.1M $224.1M $167.6M $83.6M $38.4M
Accounts Receivable $233.6M $191.1M $155.5M $151.6M $134.2M $96.4M $23.0M
Inventory $93.3M $63.0M $38.4M $51.4M $46.2M $39.8M $20.4M
Total Current Assets $808.8M $790.7M $755.0M $876.8M $570.1M $339.2M $253.0M
Property, Plant & Equipment $284.7M $264.8M $254.8M $265.7M $274.5M $303.0M $95.0M
Goodwill $92.9M $92.9M $92.9M $94.2M $92.7M $92.7M —
Intangible Assets (Excl. Goodwill) $256.2M $318.2M $379.2M $479.4M $537.6M $617.8M —
Total Assets $1.80B $1.73B $1.86B $1.92B $1.58B $1.44B $452.4M
Liabilities
Accounts Payable $55.5M $46.3M $37.4M $32.3M $19.5M $18.4M $9.3M
Total Current Liabilities $291.1M $212.0M $236.2M $130.6M $100.9M $89.2M $48.1M
Long-Term Debt $278.4M $280.7M $284.2M $349.0M $357.5M $441.4M —
Total Liabilities $594.4M $516.9M $541.5M $522.2M $512.4M $581.4M $60.4M
Stockholders' Equity
Retained Earnings $-1.04B $-947.9M $-739.5M $-512.3M $-482.3M $-524.9M $-411.2M
Total Stockholders' Equity $1.20B $1.21B $1.31B $1.40B $1.07B $853.9M $392.0M
← Newer Page 2 of 2 Older →